USD 4.93
(-6.1%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 369.29 Million USD | 51.13% |
2022 | 268.79 Million USD | 68.71% |
2021 | 159.32 Million USD | -57.5% |
2020 | 374.87 Million USD | -8.95% |
2019 | 387.58 Million USD | -23.33% |
2018 | 158.07 Million USD | -20.16% |
2017 | 232.79 Million USD | -13.97% |
2016 | 516.16 Million USD | 7.93% |
2015 | 574.91 Million USD | 32.82% |
2014 | 461.96 Million USD | 25.2% |
2013 | 427.4 Million USD | 17.56% |
2012 | 351.29 Million USD | -5.48% |
2011 | 391.99 Million USD | 2.45% |
2010 | 366.69 Million USD | 21.63% |
2009 | 311.12 Million USD | -16.57% |
2008 | 41.47 Million USD | 10.48% |
2007 | 239.2 Million USD | 127.43% |
2006 | 148.49 Million USD | 484.83% |
2005 | 9.76 Million USD | -74.86% |
2004 | 102.06 Million USD | 138.9% |
2003 | 42.72 Million USD | 70.94% |
2002 | 24.99 Million USD | 128.62% |
2001 | 10.93 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 115.19 Million USD | 22.53% |
2024 Q2 | 106.94 Million USD | -3.28% |
2023 Q4 | 103.84 Million USD | 0.1% |
2023 Q2 | 97.99 Million USD | -2.64% |
2023 FY | - USD | 51.13% |
2023 Q1 | 100.65 Million USD | 54.55% |
2023 Q3 | 103.74 Million USD | 5.86% |
2022 Q3 | 113.86 Million USD | 119.47% |
2022 Q4 | 65.12 Million USD | -42.8% |
2022 FY | - USD | 68.71% |
2022 Q1 | 36.39 Million USD | -5.88% |
2022 Q2 | 51.88 Million USD | 42.54% |
2021 Q2 | 50.4 Million USD | 38.54% |
2021 Q1 | 36.38 Million USD | -63.1% |
2021 FY | - USD | -57.5% |
2021 Q4 | 38.67 Million USD | 14.6% |
2021 Q3 | 33.74 Million USD | -33.05% |
2020 Q1 | 188.28 Million USD | 82.81% |
2020 Q2 | 48.69 Million USD | -74.14% |
2020 Q3 | 42.17 Million USD | -13.38% |
2020 Q4 | 98.59 Million USD | 133.74% |
2020 FY | - USD | -8.95% |
2019 Q1 | 120.52 Million USD | 2.15% |
2019 Q2 | 107.78 Million USD | -10.57% |
2019 Q3 | 80.42 Million USD | -25.39% |
2019 Q4 | 102.99 Million USD | 28.08% |
2019 FY | - USD | -23.33% |
2018 FY | - USD | -20.16% |
2018 Q3 | 125.05 Million USD | -18.34% |
2018 Q4 | 117.98 Million USD | -5.65% |
2018 Q2 | 153.14 Million USD | 8.77% |
2018 Q1 | 140.79 Million USD | -7.71% |
2017 Q2 | 163.48 Million USD | -22.07% |
2017 FY | - USD | -13.97% |
2017 Q1 | 209.77 Million USD | 8.22% |
2017 Q4 | 152.55 Million USD | 6.76% |
2017 Q3 | 142.88 Million USD | -12.6% |
2016 Q4 | 193.83 Million USD | -3.76% |
2016 Q1 | 184.53 Million USD | 1.95% |
2016 FY | - USD | 7.93% |
2016 Q2 | 201.69 Million USD | 9.3% |
2016 Q3 | 201.41 Million USD | -0.14% |
2015 Q3 | 166.9 Million USD | -9.93% |
2015 FY | - USD | 32.82% |
2015 Q4 | 181 Million USD | 8.45% |
2015 Q2 | 185.3 Million USD | -3.09% |
2015 Q1 | 191.22 Million USD | 18.0% |
2014 Q1 | 107.9 Million USD | -6.02% |
2014 Q2 | 111.08 Million USD | 2.95% |
2014 Q3 | 147.22 Million USD | 32.53% |
2014 FY | - USD | 25.2% |
2014 Q4 | 162.05 Million USD | 10.08% |
2013 Q2 | 102.96 Million USD | -5.83% |
2013 Q1 | 109.33 Million USD | 23.98% |
2013 Q4 | 114.81 Million USD | 5.91% |
2013 Q3 | 108.41 Million USD | 5.29% |
2013 FY | - USD | 17.56% |
2012 Q2 | 94.88 Million USD | 0.34% |
2012 Q1 | 94.56 Million USD | 2.48% |
2012 Q4 | 88.19 Million USD | 0.32% |
2012 Q3 | 87.9 Million USD | -7.36% |
2012 FY | - USD | -5.48% |
2011 Q1 | 102.22 Million USD | -1.54% |
2011 Q3 | 91.11 Million USD | -11.0% |
2011 Q4 | 92.27 Million USD | 1.28% |
2011 FY | - USD | 2.45% |
2011 Q2 | 102.36 Million USD | 0.14% |
2010 Q3 | 86.54 Million USD | -13.36% |
2010 Q4 | 103.81 Million USD | 19.95% |
2010 FY | - USD | 21.63% |
2010 Q1 | 92.51 Million USD | 25.45% |
2010 Q2 | 99.89 Million USD | 7.97% |
2009 Q3 | 110.59 Million USD | 30.24% |
2009 Q4 | 73.75 Million USD | -33.32% |
2009 FY | - USD | -16.57% |
2009 Q1 | 79.8 Million USD | -59.03% |
2009 Q2 | 84.91 Million USD | 6.41% |
2008 Q1 | 142.02 Million USD | -3.43% |
2008 Q2 | 132.1 Million USD | -6.98% |
2008 FY | - USD | 10.48% |
2008 Q4 | 194.76 Million USD | 247.61% |
2008 Q3 | 56.02 Million USD | -57.59% |
2007 Q2 | 137.35 Million USD | 9.55% |
2007 Q4 | 147.06 Million USD | 118.99% |
2007 FY | - USD | 127.43% |
2007 Q3 | 67.15 Million USD | -51.11% |
2007 Q1 | 125.37 Million USD | 230.67% |
2006 Q3 | 53.37 Million USD | 39.67% |
2006 FY | - USD | 484.83% |
2006 Q1 | 65.48 Million USD | 228.24% |
2006 Q4 | 37.91 Million USD | -28.96% |
2006 Q2 | 38.21 Million USD | -41.65% |
2005 Q3 | 4.3 Million USD | -67.26% |
2005 FY | - USD | -74.86% |
2005 Q4 | 19.95 Million USD | 363.44% |
2005 Q1 | 6.89 Million USD | 0.0% |
2005 Q2 | 13.15 Million USD | 90.66% |
2004 FY | - USD | 138.9% |
2003 FY | - USD | 70.94% |
2002 FY | - USD | 128.62% |
2001 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
agilon health, inc. | -167.64 Million USD | 320.285% |
AMN Healthcare Services, Inc. | 499.35 Million USD | 26.046% |
ATI Physical Therapy, Inc. | 82.86 Million USD | -345.644% |
Chemed Corporation | 403.69 Million USD | 8.522% |
Community Health Systems, Inc. | 1.54 Billion USD | 76.082% |
DaVita Inc. | 2.34 Billion USD | 84.262% |
Enhabit, Inc. | -16.5 Million USD | 2338.133% |
Encompass Health Corporation | 1 Billion USD | 63.28% |
HCA Healthcare, Inc. | 12.72 Billion USD | 97.097% |
Pediatrix Medical Group, Inc. | 29.88 Million USD | -1135.628% |
Select Medical Holdings Corporation | 763.61 Million USD | 51.639% |
Sonida Senior Living, Inc. | 21.72 Million USD | -1600.161% |
Solventum Corporation | 2.24 Billion USD | 83.58% |
Tenet Healthcare Corporation | 3.65 Billion USD | 89.907% |
Universal Health Services, Inc. | 1.74 Billion USD | 78.818% |
U.S. Physical Therapy, Inc. | 74.37 Million USD | -396.534% |